MARKET WIRE NEWS

Novartis: Value Price, Growth Pipeline

Source: SeekingAlpha

2026-02-05 05:51:28 ET

While many people are focusing on Tech and AI companies, I think we may have an opportunity for Value Investing within the Pharmaceutical industry, and specifically with the stock Novartis ( NVS ). Itis a great example of an underappreciated stock in the Global Pharmaceutical space. I believe this is a great time to add the stock to your Portfolio. As stated above, I believe that the company will be able to offer a combination of growing Earnings Per Share ( EPS ), expanding Margins, and a strong Pipeline, while being valued at a lower multiple than the Company's Peers....

Read the full article on Seeking Alpha

For further details see:

Novartis: Value Price, Growth Pipeline
Novartis AG

NASDAQ: NVS

NVS Trading

-0.32% G/L:

$154.04 Last:

978,559 Volume:

$154.69 Open:

mwn-ir Ad 300

NVS Latest News

NVS Stock Data

$303,205,301,793
1,889,070,162
N/A
868
N/A
Pharmaceuticals
Healthcare
CH
Basel

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App